A point-of-care testing device in pen format for the simultaneous detection of three cardiac biomarkers related to chest pain diagnosis. This product represents AssureTech's newer pen-type product line for cardiac marker detection.
Manufactured by
AssureTech.(Hangzhou) Co.,Ltd.
China
Assure Tech (Hangzhou) Co., Ltd., established in 2008, is a high-tech biotechnology company specializing in R&D, production, and sales of diagnostic reagents, POCT devices, and biological materials. The company operates a 6,000 square meter facility with colloidal gold diagnostic reagent production lines capable of producing hundreds of millions of devices annually. The R&D team of over 100 staff collaborates with domestic and international research institutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou Biotest Biotech Co., Ltd
China · 3 relevant products
Assure Tech LLC
United States · 1 relevant product
Alfa Scientific Designs, Inc.
United States · 4 relevant products
73 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 35 relevant matches
HANGZHOU LAIHE BIOTECH CO.,LTD · China
High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Quantitative fluorescence immunoassay test panels for cTnI, NT-proBNP, CK-MB, and D-Dimer that provide highly accurate concentration readouts within 15 minutes. Designed to empower chest pain centers with rapid, accurate results crucial for acute myocardial infarction intervention.
Hangzhou Biotest Biotech Co., Ltd · China
Uses highly specific antigen-antibody reactions and immunochromatographic analysis technology with colloidal gold-labeled rapid solid-phase immunochromatography to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, and plasma. The simultaneous detection of three markers provides greater clinical reference significance.
32 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products